An appraisal of drug development timelines in the Era of precision oncology-Reference-Cited by-同舟云学术

An appraisal of drug development timelines in the Era of precision oncology

Published:2016-07-13 Issue:33 Volume:7 Page:53037-53046
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Jardim Denis Leonardo¹,Schwaederle Maria²,Hong David S.³,Kurzrock Razelle²

Affiliation:

1. Department of Clinical Oncology, Hospital Sirio Libanes, Sao Paulo, Brazil

2. Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California, San Diego, CA, USA

3. Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and characterization of newly phthalocyanine molecules: Their enzyme inhibition and antioxidant properties, in silico and in vitro;Journal of Organometallic Chemistry;2024-08

2. The role of clinical imaging in oncology drug development: progress and new challenges;The British Journal of Radiology;2023-10

3. Integrating Early-Stage Drug Development with Clinical Networks; Challenges and Opportunities: The City of Hope Developing Experience;Journal of Clinical Medicine;2023-06-15

4. Synthesis of Some New 1,2,3-Triazole-Arylidenehydrazide Hybrid Compounds and Determination of Their Antimicrobial Activities;Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi;2023-03-01

5. Immuno-oncology trends: preclinical models, biomarkers, and clinical development;Journal for ImmunoTherapy of Cancer;2022-01